BIORBYT LTD. Non-Antibody Products — page 1 of 5
Non-Antibody Products
Page 1,034 of 5,306
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Everolimus | n/a | 10 mg, 50 mg, 100 mg | orb1904540 | More Info |
| Everolimus EP Impurity B | Purity ≥96% (mix of E / Z). MW: 958.2 | 25 mg, 10 mg, 5 mg | orb1821699 | More Info |
| Everolimus EP Impurity E | Purity ≥80%. MW: 942.18 | 25 mg, 10 mg, 5 mg | orb1476680 | More Info |
| Everolimus (RAD001) | Purity > 98%. MW: 958.22 | 20 mg | orb1102136 | More Info |
| Everolimus (RAD001) | n/a | 10 mm | orb1904539 | More Info |
| EVER1 Peptide | n/a | 0.05 mg | orb1234223 | More Info |
| EVER2 Peptide | n/a | 0.05 mg | orb1233382 | More Info |
| EVI2A | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb596155 | More Info |
| EVI2A Human Over-expression Lysate | EVI2A HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1368212 | More Info |
| EVI2A Human Over-expression Lysate | Transient overexpression lysate of ecotropic viral integration site 2A (EV… | 100 ug | orb1347872 | More Info |
| EVI2A siRNA (Human) | siRNA to inhibit EVI2A expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866781 | More Info |
| EVI2A siRNA (Mouse) | siRNA to inhibit EVI2A expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1848019 | More Info |
| EVI2B Human Over-expression Lysate | EVI2B HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1367384 | More Info |
| EVI2B Human Over-expression Lysate | Transient overexpression lysate of ecotropic viral integration site 2B (EV… | 100 ug | orb1347045 | More Info |
| EVI2B siRNA (Human) | siRNA to inhibit EVI2B expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866780 | More Info |
| EVI2B siRNA (Mouse) | siRNA to inhibit EVI2B expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1837197 | More Info |
| Evifacotrep | Purity 98.00%. MW: 441.77 | 1 mg, 25 mg, 100 mg, 50 mg, 10 mg, 5 mg, 500 mg | orb1303317 | More Info |
| EVI5 Human Over-expression Lysate | EVI5 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1377851 | More Info |
| EVI5 Human Over-expression Lysate | Transient overexpression lysate of ecotropic viral integration site 5 (EVI… | 100 ug | orb1357516 | More Info |
| EVI5L | n/a | 10 ug | orb531911 | More Info |
| EVI5L Human Over-expression Lysate | EVI5L HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1373397 | More Info |
| EVI5L Human Over-expression Lysate | Transient overexpression lysate of ecotropic viral integration site 5-like… | 100 ug | orb1353061 | More Info |
| EVI5L siRNA (Human) | siRNA to inhibit EVI5L expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1853798 | More Info |
| EVI1 (MECOM) Human Over-expression Lysate | MECOM HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1361726 | More Info |
| EVI1 (MECOM) Human Over-expression Lysate | Transient overexpression lysate of MDS1 and EVI1 complex locus (MECOM), tr… | 100 ug | orb1357621 | More Info |
| EVI1 (MECOM) Human Over-expression Lysate | Transient overexpression lysate of MDS1 and EVI1 complex locus (MECOM), tr… | 100 ug | orb1341449 | More Info |
| EVI5 siRNA (Human) | siRNA to inhibit EVI5 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1862974 | More Info |
| Evista | n/a | 50 mg, 100 mg, 10 mm | orb1904536 | More Info |
| Evixapodlin | Purity 98.00%. MW: 691.61 | 25 mg, 10 mg, 1 mg, 100 mg, 5 mg, 50 mg | orb1693690 | More Info |
| EVL | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb603323 | More Info |
| EVL | n/a | 10 ug | orb530072 | More Info |
| EVL Human Over-expression Lysate | EVL HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1369196 | More Info |
| EVL Human Over-expression Lysate | Transient overexpression lysate of Enah / Vasp-like (EVL) | 100 ug | orb1348856 | More Info |
| EVL Immunizing peptide | n/a | 100 ug | orb55056 | More Info |
| EVL Peptide | n/a | 0.1 mg | orb1236332 | More Info |
| EVL siRNA (Human) | siRNA to inhibit EVL expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1858479 | More Info |
| EVL siRNA (Mouse) | siRNA to inhibit EVL expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1848017 | More Info |
| EVL siRNA (Rat) | siRNA to inhibit EVL expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1831761 | More Info |
| Evocalcet | Evocalcet (KHK7580) is an novel oral calcimimetic agent which acts via all… | 1 g, 250 mg, 100 mg | orb1785975 | More Info |
| Evocalcet | Evocalcet has an activating effect on the calcium-sensing receptor (CaSR).… | 50 mg, 200 mg, 100 mg, 25 mg, 10 mg, 5 mg | orb1219698 | More Info |
| Evocalcet | Purity 99.83%. MW: 374.48 | 200 mg, 5 mg, 10 mg, 100 mg, 50 mg, 25 mg, 500 mg, 1 mg | orb1308317 | More Info |
| Evocarpine | Evocarpine shows antimycobacterial, and vasorelaxant effects, it can inhib… | 50 mg, 25 mg, 10 mg, 5 mg | orb1218757 | More Info |
| Evocarpine | MW: 339.523 | 2 mg | orb1479424 | More Info |
| Evocarpine | Purity > 98%. MW: 339.52 | 10 mg | orb1290656 | More Info |
| Evocarpine | Purity 98.0% (HPLC). | 10 mg, 25 mg | orb1176434 | More Info |
| Evocarpine | Purity 99.77%. MW: 339.51 | 10 mg, 5 mg, 25 mg, 50 mg, 1 mg | orb1297543 | More Info |
| Evodenoson | Purity 98.00%. MW: 499.52 | 25 mg, 10 mg, 1 mg, 50 mg, 100 mg, 5 mg | orb1697251 | More Info |
| Evodiamine | Purity 98.0% (HPLC) | 25 mg, 1000 mg | orb701259 | More Info |
| Evodiamine | MW: 303.365 | 20 mg | orb593923 | More Info |
| Evodiamine | Purity ≥98%. MW: 303.36 | 1 g, 250 mg, 100 mg | orb322476 | More Info |
| Evodiamine | Purity ≥98%. MW: 303.36 | 1 g, 20 mg | orb557326 | More Info |
| Evodiamine | Purity > 98%,Standard References. MW: 303.36 | 20 mg | orb422127 | More Info |
| Evodiamine | Purity > 98%. MW: 303.36 | 250 mg, 50 mg | orb546040 | More Info |
| Evodiamine | Purity 98.5% (HPLC&TLC). | 25 mg | orb703677 | More Info |
| Evodiamine | Purity 99.94%. MW: 303.35 | 20 mg, 250 mg, 100 mg, 50 mg | orb1304910 | More Info |
| Evodiamine | n/a | 25 mg, 100 mg | orb1904534 | More Info |
| Evodia Standards Kit | n/a | 1 kit | orb322056 | More Info |
| Evodine | Purity > 98%,Standard References. MW: 329.35 | 20 mg | orb105586 | More Info |
| Evodine | Purity > 98%. MW: 329.35 | 5 mg | orb1103452 | More Info |
| Evodol | Purity > 98%. MW: 484.5 | 5 mg | orb558325 | More Info |
| Evofolin B | Purity > 98%. MW: 318.3 | 5 mg | orb1104936 | More Info |
| Evofolin C | MW: 218.296 | 2 mg | orb1479462 | More Info |
| Evofolin C | Purity ≥98%. MW: 218.3 | 5 mg | orb1103551 | More Info |
| Evofosfamide | A potent and selective hypoxia-activated phosphoramidate DNA cross-linking… | 100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1223649 | More Info |
| Evofosfamide | Purity 99.75%. MW: 449.04 | 2 mg, 10 mg, 25 mg, 50 mg, 100 mg, 5 mg, 1 mg | orb1303995 | More Info |
| Evofosfamide(TH-302) | TH-302 is selective hypoxia-activated prodrug targeting hypoxic regions of… | 1000 mg, 100 mg, 250 mg, 10 mM * 1 mL in DMSO | orb198448 | More Info |
| Evogliptin | Purity 98.00%. MW: 401.42 | 5 mg, 50 mg, 100 mg | orb1688089 | More Info |
| Evogliptin HCl | Purity 98.00%. MW: 437.88 | 5 mg, 50 mg, 100 mg | orb1697250 | More Info |
| Evogliptin tartrate | Purity 98.00%. MW: 551.51 | 100 mg, 50 mg, 5 mg | orb1709723 | More Info |
| Evolitrine | MW: 229.235 | 10 mg | orb758030 | More Info |
| Evolitrine | Purity 98.0% (HPLC). | 10 mg, 25 mg | orb1176433 | More Info |
| Evolitrine | Purity 99.03%. MW: 229.23 | 20 mg, 50 mg, 25 mg, 10 mg, 5 mg, 1 mg | orb1299122 | More Info |
| Evolocumab | Evolocumab is a human IgG2 monoclonal antibody that binds to human PCSK9 P… | 5 mg | orb1219980 | More Info |
| Evolocumab | Purity 98.00%. MW: 144 kDa | 5 mg, 50 mg, 25 mg, 10 mg, 1 mg | orb1297795 | More Info |
| Evonimine | Purity > 98%. MW: 805.8 | 5 mg | orb1103385 | More Info |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Return to Profile